Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz, Ph.D.

8/6/2026; 13 minutes

Alzheimer's disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models' ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Recorded on 05/27/2026. (#41632)

Watch video with audio description on YouTube (opens in new tab)View Transcript (PDF) (opens in new tab)Listen to audio (MP3) (opens in new tab)Watch video (MP4) (opens in new tab)
Like what you learn?

Donate to UCTV to support informative & inspiring programming.
Links & Resources